0001181431-13-000830.txt : 20130103
0001181431-13-000830.hdr.sgml : 20130103
20130103143840
ACCESSION NUMBER: 0001181431-13-000830
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121231
FILED AS OF DATE: 20130103
DATE AS OF CHANGE: 20130103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SMITH TODD N
CENTRAL INDEX KEY: 0001523672
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35238
FILM NUMBER: 13505953
MAIL ADDRESS:
STREET 1: 1033 SKOKIE BOULEVARD
STREET 2: SUITE 355
CITY: NORTHBROOK
STATE: IL
ZIP: 60062
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HORIZON PHARMA, INC.
CENTRAL INDEX KEY: 0001492426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 272179987
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 520 LAKE COOK ROAD
STREET 2: SUITE 520
CITY: DEERFIELD
STATE: IL
ZIP: 60062
BUSINESS PHONE: 224-383-3000
MAIL ADDRESS:
STREET 1: 520 LAKE COOK ROAD
STREET 2: SUITE 520
CITY: DEERFIELD
STATE: IL
ZIP: 60062
4
1
rrd363760.xml
X0306
4
2012-12-31
0
0001492426
HORIZON PHARMA, INC.
HZNP
0001523672
SMITH TODD N
C/O HORIZON PHARMA, INC.
520 LAKE COOK ROAD, SUITE 520
DEERFIELD
IL
60015
0
1
0
0
EVP & Chief Commercial Officer
Common Stock
2012-12-31
4
A
0
22500
0
A
29568
D
Common stock
2013-01-02
4
S
0
6998
2.36
D
22570
D
Employee stock options (right to buy)
2.40
2013-01-02
4
A
0
61000
0
A
2023-01-01
common stock
61000
61000
D
Restricted stock units
2013-01-02
4
A
0
55000
0
A
common stock
55000
55000
D
On January 3, 2012, the reporting person was granted restricted stock units which vest upon the achievement of certain performance criteria. On December 31, 2012, 22,500 of these restricted stock units vested in connection with the achievement of certain of these performance related goals. No unvested restricted stock units with respect to this grant were outstanding after the completion of this transaction.
Includes 3,719 shares of the Company's common stock acquired pursuant to an employee stock purchase program.
Reflects shares of common stock surrendered via open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in December 2012, in order to satisfy certain tax withholding obligations.
The shares subject to the option vest and become exercisable in forty-eight equal monthly installments from the vesting commencement date of January 2, 2013.
Each restricted stock unit represents a contingent right to receive one share of Horizon Pharma, Inc. common stock.
The restricted stock units vest in four equal annual installments beginning January 2, 2014.
/s/ Robert J. De Vaere, Attorney-In-Fact
2013-01-03